Clinical trial
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With…
NCT00073905 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00073905 |
|---|---|
| Title | Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer |
| Official title | Capecitabine And Gemcitabine In Patients With Advanced Or Metastatic Biliary Tract Cancer, A Multicenter Phase II Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Pain |
| Intervention type | Drug |
| Interventions | capecitabine plus gemcitabine |
| Enrollment | 44 |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Dec 11, 2003 |
| Last update posted | Jun 5, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: